Hao et al.
FULL PAPER
2,2,2-Trifluoro-N-[2-(naphthalen-2-yloxy)-phen-
(M+) 295.0820, found 295.0817.
2,2,2-Trifluoro-N-[2-(2-isopropyl-phenoxy)-phen-
yl]-acetamide (3l) 1H NMR (CDCl3, 300 MHz) δ:
yl]-acetamide (3f) 1H NMR (CDCl3, 300 MHz) δ:
8.65 (s, 1H), 8.42 (dd, J1=1.5 Hz, J2=7.5 Hz, 1H),
7.87 (t, J=9.0 Hz, 2H), 7.74 (d, J=7.2 Hz, 1H), 7.52—
8.69 (s, 1H), 8.42—8.39 (m, 1H), 7.42—7.39 (m, 1H),
7.41 (m, 3H), 7.26 (dd, J1=2.4 Hz, J2=9.0 Hz, 1H),
7.24—7.20 (m, 2H), 7.12—7.09 (m, 2H), 6.94—6.91
7.22—7.08 (m, 2H), 6.89 (dd, J1=1.5 Hz, J2=9.0 Hz,
(m, 1H), 6.73—6.69 (m, 1H), 3.25—3.11 (m, 1H), 1.24
1H); 13C NMR (CDCl3, 100 MHz) δ: 154.63 (q, J=37.4
Hz), 153.16, 146.81, 134.18, 130.82, 130.48, 127.87,
127.31, 126.99, 126.78, 126.24, 125.52, 123.94, 121.16,
119.54, 117.29, 115.65 (q, J=287.1 Hz), 115.32; EI-
MS m/z: 331 (M+); EI-HRMS calcd for C18H12F3NO2
(M+) 331.0820, found 331.0813.
(d, J=6.6 Hz, 6H); 13C NMR (CDCl3, 100 MHz) δ:
154.52 (q, J=37.2 Hz), 151.96, 147.40, 140.28, 127.45,
127.24, 126.09, 125.99, 125.51, 123.01, 120.82, 119.98,
115.39, 115.61 (q, J=287.2 Hz), 27.25, 22.95 (2C);
EI-MS m/z: 323 (M+); EI-HRMS calcd for C17H16-
F3NO2 (M+) 323.1133, found 323.1135.
2,2,2-Trifluoro-N-(2-m-tolyloxy-phenyl)-acetamide
2,2,2-Trifluoro-N-[2-(2-methoxy-phenoxy)-phen-
(3g) 1H NMR (CDCl3, 300 MHz) δ: 8.51 (s, 1H), 8.32
yl]-acetamide (3m) 1H NMR (CDCl3, 300 MHz) δ:
—8.28 (m, 1H), 7.19 (t, J=7.8 Hz, 1H), 7.05—7.02 (m,
8.94 (s, 1H), 8.35 (d, J=8.4 Hz, 1H), 7.25—6.96 (m,
for C15H12F3NO3 (M ) 311.0769, found 311.0767.
2H), 6.93 (d, J=7.5 Hz, 1H), 6.7+9 (m, 2H), 6.76 (s, 1H),
2.27 (s, 3H); EI-MS m/z: 295 (M ); EI-HRMS calcd for
C15H12F3NO2 (M+) 295.0820, found 295.0822.
6H), 6.82 (d, J=7.5 Hz, 1H), 3.80 (s, 3H); 13C NMR
(CDCl3, 100 MHz) δ: 154.55 (q, J=37.1 Hz), 151.34,
147.56, 143.87, 126.30, 126.25, 125.86, 123.31, 122.16,
121.15, 120.81, 116.10, 115.71 (q, J = 287.7 Hz),
112.69, 55.71; EI-M+S m/z: 311 (M+); EI-HRMS calcd
2,2,2-Trifluoro-N-[2-(3-isopropyl-phenoxy)-phen-
yl]-acetamide (3h)8 1H NMR (CDCl3, 300 MHz) δ:
8.66 (s, 1H), 8.43—8.40 (m, 1H), 7.34 (t, J=8.1 Hz,
1H), 7.16—7.10 (m, 3H), 7.00 (s, 1H), 6.91—6.88 (m,
2,2,2-Trifluoro-N-[2-(2,4,6-trimethyl-phenoxy)-
2H), 2.99—2.90 (m, 1H), 1.29 (d, J=6.9 Hz, 6H); 13C
phenyl]-acetamide (3n) 1H NMR (CDCl3, 300 MHz)
NMR (CDCl3, 100 MHz) δ: 155.42, 154.77 (q, J=37.3
δ: 8.80 (s, 1H), 8.39 (d, J=9.0 Hz, 1H), 7.03—7.01 (m,
Hz), 151.71, 147.03, 129.93, 126.55, 126.12, 123.48,
2H), 6.94 (s, 2H), 6.42 (d, J=9.0 Hz, 1H), 2.32 (s, 3H),
122.97, 121.02, 117.56, 116.78, 116.63, 115.65 (q, J+=
287.1 Hz), 34.06, 23.81 (2C); EI-MS m+/z: 323 (M );
EI-HRMS calcd for C17H16F3NO2 (M ) 323.1133,
found 323.1137.
2.07 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ: 154.48 (q,
J=37.8 Hz), 147.87, 146.53, 135.46, 130.62 (2C),
129.88 (2C), 126.01, 124.65, 121.98, 120.51, 120.05,
115.63 (q, J=284.4 Hz), 20.78, 16.05 (2C); EI-MS m+/z:
323 (M+ ); EI-HRMS calcd for C17H16F3NO2 (M )
323.1133, found 323.1131.
N-[2-(3-Dimethylamino-phenoxy)-phenyl]-2,2,2-
trifluoro-acetamide (3i) 1H NMR (CDCl3, 300 MHz)
δ: 8.63 (s, 1H), 8.39—8.36 (m, 1H), 7.22 (t, J=9.0 Hz,
N-[2-(4-Chloro-phenoxy)-phenyl]-2,2,2-trifluoro-
1H), 7.13—7.09 (m, 2H), 6.91—6.88 (m, 1H ), 6.55 (d,
acetamide (3o) 1H NMR (CDCl3, 300 MHz) δ: 8.54
J=8.1 Hz, 1H), 6.42 (s, 1H), 6.36 (d, J=7.8 Hz, 1H),
(s, 1H), 8.38—8.35 (m, 1H), 7.35 (d, J=8.1 Hz, 2H),
2.96 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ: 156.44,
7.16—7.13 (m, 2H), 7.01 (d, J=9.0 Hz, 2H), 6.86—
154.54 (q, J=36.9 Hz), 152.19, 147.04, 130.31, 126.48,
126.02, 123.29, 120.78, 116.89, 115.63 (q, J=287.2
Hz), 108.82, 106.83, 103.46, 40.40 (2C); EI-MS m/z:
324 (M+); EI-HRMS calcd for C16H15F3N2O2 (M+)
324.1086, found 324.1084.
6.83 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ: 154.56 (q,
J=37.4 Hz), 154.03, 146.46, 130.18 (2C), 129.97,
126.63, 126.25, 124.14, 121.26, 120.59 (2C), 116.+91,
115.55 (q, J=287.5 Hz); EI-MS m/z: 315 (M );
EI-HRMS calcd for C14H9ClF3NO2 (M+ ) 315.0274,
found 315.0278.
N-[2-(3,5-Dimethyl-phenoxy)-phenyl]-2,2,2-trifluo-
roacetamide (3j) 1H NMR (CDCl3, 300 MHz) δ: 8.65
2,2,2-Trifluoro-N-(2-(4-fluorophenoxy)phenyl)-
(s, 1H), 8.43—8.40 (m, 1H), 7.16—7.13 (m, 2H), 6.91
acetamide (3p) 1H NMR (CDCl3, 300 MHz) δ: 8.58
—6.87 (m, 2H), 6.72 (s, 2H), 2.34 (s, 6H); 13C NMR
(CDCl3, 100 MHz) δ: 155.47, 154.53 (q, J=32.6 Hz),
146.95, 140.13 (2C), 126.66, 126.41, 126.09, 123.48,
120.90, 117.08, 116.93 (2C), 11+5.65 (q, J=286.5 Hz),
21.22 (2C); EI-MS m/z: 309 (M ); EI-HRMS calcd for
(s, 1H), 8.40—8.36 (m, 1H), 7.17—7.02 (m, 6H), 6.81
—6.77 (m, 1H); EI-MS m/z: 299 (M+); EI-HRMS calcd
for C14H9F4NO2 (M+) 299.0569, found 299.0566.
2,2,2-Trifluoro-N-[2-(3-trifluoromethyl-phenoxy)-
phenyl]-acetamide (3q) 1H NMR (CDCl3, 300 MHz)
C16H14F3NO2 (M+) 309.0977, found 309.0969.
δ: 8.50 (s, 1H), 8.40 (dd, J1=2.1 Hz, J2=7.5 Hz, 1H),
2,2,2-Trifluoro-N-(2-(o-tolyloxy)phenyl)acetamide
7.56—7.46 (m, 2H), 7.35 (s, 1H), 7.26—7.15 (m, 3H),
(3k) 1H NMR (CDCl3, 300 MHz) δ: 8.69 (s, 1H), 8.41
6.90—6.87 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ:
—8.38 (m, 1H), 7.30 (d, J=76.9 Hz, 1H), 7.25—7.14
155.87, 154.67 (q, J=39.2 Hz), 146.00, 132.76 (q, J=
(m, 2H), 7.12—7.04 (m, 2H), 6.96 (d, J=7.8 Hz, 1H),
33.4 Hz), 130.83, 126.83, 126.43, 124.62, 123.42 (q,
6.66—6.63 (m, 1H), 2.22 (s, 3H); 13C NMR (CDCl3,
100 MHz) δ: 154.54 (q, J=37.5 Hz), 152.84, 147.04,
131.87, 130.09, 127.58, 126.08, 125.77, 125.38, 122.93,
120.84, 120.22, 115.67 (q, J=287.3 Hz), 115.02, 15.96;
EI-MS m/z: 295 (M+); HRMS calcd for C15H12F3NO2
J=271.1 Hz), 122.29, 121.54, 121.36 (q, J=3.8 Hz),
117.32, 116.18 (q, J+=4.3 Hz), 115.30 (q, J=287.2 Hz);
EI-MS m/z: 349 (M ); EI-HRMS calcd for C15H9F6NO2
(M+) 349.0537, found 349.0533.
N-[2-(3-Acetyl-phenoxy)-phenyl]-2,2,2-trifluoro-
1648
© 2010 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2010, 28, 1645— 1650